Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideTreatment OutcomeDoxorubicinPeripheral NervesNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsPeripheral Nervous System DiseasesDrug Administration ScheduleMethotrexatePeripheral Nervous SystemCarboplatinPaclitaxelVinblastineInduction ChemotherapyNeoplasm Recurrence, LocalTaxoidsTime FactorsIfosfamideNeoplasmsPeripheral Vascular DiseasesDrug Resistance, NeoplasmBleomycinOrganoplatinum CompoundsDeoxycytidineAntimetabolites, AntineoplasticFollow-Up StudiesTransplantation, AutologousAntineoplastic Agents, AlkylatingCytarabineSalvage TherapyAnthracyclinesLeukocytes, MononuclearCarcinoma, Non-Small-Cell LungChemotherapy, Cancer, Regional PerfusionLymphoma, Non-HodgkinNeoplasm MetastasisGranulocyte Colony-Stimulating FactorOvarian NeoplasmsNeutropeniaProspective StudiesHematopoietic Stem Cell TransplantationAdenocarcinomaHodgkin DiseaseTesticular NeoplasmsVomitingAntineoplastic Agents, PhytogenicDose-Response Relationship, DrugNauseaPeripheral Nerve InjuriesRadiotherapy, AdjuvantPeripheral Arterial DiseaseColorectal NeoplasmsLymphoma, T-Cell, PeripheralRadiotherapyAntibiotics, AntineoplasticClinical Trials as TopicAntibodies, MonoclonalCarmustineKaplan-Meier EstimateDacarbazineNeoplasms, Germ Cell and EmbryonalMelphalanBrain NeoplasmsTumor Markers, BiologicalInfusions, IntravenousRecurrenceBone NeoplasmsLomustineCamptothecinLeukopeniaThiotepaInfusions, Intra-ArterialPlatinum CompoundsMitomycinOsteosarcomaLiver NeoplasmsCell Line, TumorPeripheral Blood Stem Cell TransplantationAntiemeticsFlow CytometryMitoxantroneLymphocytesPeritoneal NeoplasmsLymphomaDisease ProgressionDrug TherapyLymphatic MetastasisStomach Neoplasms